F
Francisco Marín
Researcher at University of Murcia
Publications - 503
Citations - 13444
Francisco Marín is an academic researcher from University of Murcia. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 53, co-authored 439 publications receiving 11660 citations. Previous affiliations of Francisco Marín include Carlos III Health Institute & Services Hospital.
Papers
More filters
Journal ArticleDOI
Uses and properties of Citrus flavonoids
TL;DR: The antioxidant capacity of any flavonoid will be determined by a combination of the O-dihydroxy structure in the B-ring, the 2,3-double bond in conjugation with a 4-oxo function and the presence of both hydroxyl groups in positions 3 and 5.
Journal ArticleDOI
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)
Gregory Y.H. Lip,Stephan Windecker,Kurt Huber,Paulus Kirchhof,Francisco Marín,Jurriën M. ten Berg,Karl Georg Haeusler,Giuseppe Boriani,Davide Capodanno,Martine Gilard,Uwe Zeymer,Deirdre A. Lane,Robert F. Storey,Héctor Bueno,Jean-Philippe Collet,Laurent Fauchier,Sigrun Halvorsen,Maddalena Lettino,João Morais,Christian Mueller,Tatjana S. Potpara,Lars Hvilsted Rasmussen,Andrea Rubboli,Juan Tamargo,Marco Valgimigli,José Luis Zamorano +25 more
TL;DR: Effective stroke prevention (which is essentially OAC) can then be offered to AF patients with ≥1 stroke risk factor(s), with treatment decisions made in consultation with patients and incorporating their preferences.
Journal ArticleDOI
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
Gregory Y.H. Lip,Kurt Huber,Felicita Andreotti,Harald Arnesen,K. J. Airaksinen,Thomas Cuisset,Paulus Kirchhof,Francisco Marín +7 more
TL;DR: In this article, a consensus document comprehensively reviews the published evidence and presents a consensus statement on a "best practice" antithrombotic therapy guideline for the management of atrial fibrillation patients.
Journal ArticleDOI
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Juan M. Ruiz-Nodar,Francisco Marín,José Hurtado,José Valencia,Eduardo Pinar,Javier Pineda,Juan R. Gimeno,Francisco Sogorb,Mariano Valdés,Gregory Y.H. Lip +9 more
TL;DR: Patients with AF undergoing PCI with stenting represent a high-risk population because of age, comorbidities, and presence of stroke risk factors and have a high mortality and MACE rate, which is reduced by anticoagulation therapy.
Journal ArticleDOI
Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis.
Gregory Y.H. Lip,Felicita Andreotti,Laurent Fauchier,Kurt Huber,Elaine M. Hylek,Eve Knight,Deirdre A. Lane,Marcel Levi,Francisco Marín,Gualtiero Palareti,Paulus Kirchhof +10 more
TL;DR: The main aim of the document was to summarise 'best practice' in dealing with bleeding risk in AF patients when approaching antithrombotic therapy, by addressing the epidemiology and size of the problem, and review established bleeding risk factors.